Forbes Medi-Tech Announces Launch of Reducol(tm)-Based Products at Albert Heijn

Forbes Medi-Tech Announces Launch of Reducol(tm)-Based Products at Albert Heijn The Netherlands's largest retailer, Albert Heijn, has launched a range of cholesterol-lowering dairy products incorporating Forbes Medi-Tech's cholesterol-lowering ingredient, Reducol(tm). The product range, marketed under the Albert Heijn private label brand, will include: a margarine spread, a spoonable yogurt, and 'original' and 'strawberry flavor' yogurt drinks.
Home Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P. Natrol Appoints Vincent Andrich VP Sales for Prolab Division Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results Body Shop Reports 24.8 Mil Euro Sales Revenues Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label Supplement Group Targets Consumer Education Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO drugstore.com Expects to Reach Profitability Target in 2003 Human Genome Project Leads to Innovative Healthcare NPIcenter’s Career Center targets nutraceutical Industry Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Editorial: An Exercise in Synergy NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway Natural Health Trends Corp. Launches Lexxus Taiwan FDA Presents Compliance Guide for Structure/Function Claims New TrimFit® Bars Redefine Energy Bar Category New TrimFit® Bars Redefine Energy Bar Category Probiata® Offers Safe, Natural and Effective Alternative Alive & Well with Michelle Harris Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com Consumers Search for Healthy Cleaning Products That Work Nordic Naturals: Omega 3 Fatty Acids Cyanotech Names Bob Capelli as Director of Sales Treatt Brings Out the Best In Blueberries Company has introduced Blueberry Treattarome™ 9840 to its expanding range of 100% natural, FTNF (From The Named Food) flavor ingredients, wholly distilled from top grade, freshly cultivated berries. Herbal Remedy Could Help Sufferers of Type 2 Diabetes British researchers, in a placebo controlled study on 79 subjects, set out to see if patients with type 2 diabetes, consuming a western diet and taking prescribed medication with daily hawthorn extract would show greater hypotensive effects over 16 weeks than a placebo group. The researhcers observed that those taking the hawthorn, after a 16 week period, had a significant reduction of 2.6 mmHg in their diastolic blood pressure. Herbal Remedy Could Help Sufferers of Type 2 Diabetes British researchers, in a placebo controlled study on 79 subjects, set out to see if patients with type 2 diabetes, consuming a western diet and taking prescribed medication with daily hawthorn extract would show greater hypotensive effects over 16 weeks than a placebo group. The researhcers observed that those taking the hawthorn, after a 16 week period, had a significant reduction of 2.6 mmHg in their diastolic blood pressure. Herbal Remedy Could Help Sufferers of Type 2 Diabetes British researchers, in a placebo controlled study on 79 subjects, set out to see if patients with type 2 diabetes, consuming a western diet and taking prescribed medication with daily hawthorn extract would show greater hypotensive effects over 16 weeks than a placebo group. The researhcers observed that those taking the hawthorn, after a 16 week period, had a significant reduction of 2.6 mmHg in their diastolic blood pressure. Herbal Remedy Could Help Sufferers of Type 2 Diabetes British researchers, in a placebo controlled study on 79 subjects, set out to see if patients with type 2 diabetes, consuming a western diet and taking prescribed medication with daily hawthorn extract would show greater hypotensive effects over 16 weeks than a placebo group. The researhcers observed that those taking the hawthorn, after a 16 week period, had a significant reduction of 2.6 mmHg in their diastolic blood pressure. Herbal Remedy Could Help Sufferers of Type 2 Diabetes British researchers, in a placebo controlled study on 79 subjects, set out to see if patients with type 2 diabetes, consuming a western diet and taking prescribed medication with daily hawthorn extract would show greater hypotensive effects over 16 weeks than a placebo group. The researhcers observed that those taking the hawthorn, after a 16 week period, had a significant reduction of 2.6 mmHg in their diastolic blood pressure. Herbal Remedy Could Help Sufferers of Type 2 Diabetes British researchers, in a placebo controlled study on 79 subjects, set out to see if patients with type 2 diabetes, consuming a western diet and taking prescribed medication with daily hawthorn extract would show greater hypotensive effects over 16 weeks than a placebo group. The researhcers observed that those taking the hawthorn, after a 16 week period, had a significant reduction of 2.6 mmHg in their diastolic blood pressure. Herbal Remedy Could Help Sufferers of Type 2 Diabetes British researchers, in a placebo controlled study on 79 subjects, set out to see if patients with type 2 diabetes, consuming a western diet and taking prescribed medication with daily hawthorn extract would show greater hypotensive effects over 16 weeks than a placebo group. The researhcers observed that those taking the hawthorn, after a 16 week period, had a significant reduction of 2.6 mmHg in their diastolic blood pressure. Herbal Remedy Could Help Sufferers of Type 2 Diabetes British researchers, in a placebo controlled study on 79 subjects, set out to see if patients with type 2 diabetes, consuming a western diet and taking prescribed medication with daily hawthorn extract would show greater hypotensive effects over 16 weeks than a placebo group. The researhcers observed that those taking the hawthorn, after a 16 week period, had a significant reduction of 2.6 mmHg in their diastolic blood pressure. New CEO Boosts Vitiva's Growth Company reports 250% sales growth and improved profitability. New CEO Boosts Vitiva's Growth Company reports 250% sales growth and improved profitability. New CEO Boosts Vitiva's Growth Company reports 250% sales growth and improved profitability. New CEO Boosts Vitiva's Growth Company reports 250% sales growth and improved profitability. New CEO Boosts Vitiva's Growth Company reports 250% sales growth and improved profitability. Vitamin Angel Alliance Organizes Nutrition Response for Indonesia Earthquake Relief Effort Vitamin Angel Alliance has begun organizing children’s and adult multiple vitamin shipments to assist in the Indonesia Earthquake Relief effort and is now beginning to receive vitamin donations in Los Angeles that will be air freighted along with other relief supplies to the earthquake region as early as this week. Vitamin Angel Alliance Organizes Nutrition Response for Indonesia Earthquake Relief Effort Vitamin Angel Alliance has begun organizing children’s and adult multiple vitamin shipments to assist in the Indonesia Earthquake Relief effort and is now beginning to receive vitamin donations in Los Angeles that will be air freighted along with other relief supplies to the earthquake region as early as this week. Vitamin Angel Alliance Organizes Nutrition Response for Indonesia Earthquake Relief Effort Vitamin Angel Alliance has begun organizing children’s and adult multiple vitamin shipments to assist in the Indonesia Earthquake Relief effort and is now beginning to receive vitamin donations in Los Angeles that will be air freighted along with other relief supplies to the earthquake region as early as this week. Vitamin Angel Alliance Organizes Nutrition Response for Indonesia Earthquake Relief Effort Vitamin Angel Alliance has begun organizing children’s and adult multiple vitamin shipments to assist in the Indonesia Earthquake Relief effort and is now beginning to receive vitamin donations in Los Angeles that will be air freighted along with other relief supplies to the earthquake region as early as this week. Vitamin Angel Alliance Organizes Nutrition Response for Indonesia Earthquake Relief Effort Vitamin Angel Alliance has begun organizing children’s and adult multiple vitamin shipments to assist in the Indonesia Earthquake Relief effort and is now beginning to receive vitamin donations in Los Angeles that will be air freighted along with other relief supplies to the earthquake region as early as this week. Metagenics Expands Direct International Presence with Acquisition of Belgian Nutraceutical Manufacturer and Distributor Company announces that it has concluded the acquisition of Biodynamics NV, a leading manufacturer and distributor of nutraceuticals to healthcare professionals, pharmacies, health food stores, and veterinarians in the Benelux countries--Belgium, The Netherlands, and Luxembourg. Metagenics Expands Direct International Presence with Acquisition of Belgian Nutraceutical Manufacturer and Distributor Company announces that it has concluded the acquisition of Biodynamics NV, a leading manufacturer and distributor of nutraceuticals to healthcare professionals, pharmacies, health food stores, and veterinarians in the Benelux countries--Belgium, The Netherlands, and Luxembourg. Metagenics Expands Direct International Presence with Acquisition of Belgian Nutraceutical Manufacturer and Distributor Company announces that it has concluded the acquisition of Biodynamics NV, a leading manufacturer and distributor of nutraceuticals to healthcare professionals, pharmacies, health food stores, and veterinarians in the Benelux countries--Belgium, The Netherlands, and Luxembourg. Metagenics Expands Direct International Presence with Acquisition of Belgian Nutraceutical Manufacturer and Distributor Company announces that it has concluded the acquisition of Biodynamics NV, a leading manufacturer and distributor of nutraceuticals to healthcare professionals, pharmacies, health food stores, and veterinarians in the Benelux countries--Belgium, The Netherlands, and Luxembourg. Metagenics Expands Direct International Presence with Acquisition of Belgian Nutraceutical Manufacturer and Distributor Company announces that it has concluded the acquisition of Biodynamics NV, a leading manufacturer and distributor of nutraceuticals to healthcare professionals, pharmacies, health food stores, and veterinarians in the Benelux countries--Belgium, The Netherlands, and Luxembourg. Metagenics Expands Direct International Presence with Acquisition of Belgian Nutraceutical Manufacturer and Distributor Company announces that it has concluded the acquisition of Biodynamics NV, a leading manufacturer and distributor of nutraceuticals to healthcare professionals, pharmacies, health food stores, and veterinarians in the Benelux countries--Belgium, The Netherlands, and Luxembourg. Encouraging Results for Folic Acid for Cancer Prevention Small study in CANCER indicates finds that 31 of 43 patients with the precancerous laryngeal lesion called leucoplakia demonstrated 50 percent or greater reduction in the lesion size after six months of taking folate supplements. Encouraging Results for Folic Acid for Cancer Prevention Small study in CANCER indicates finds that 31 of 43 patients with the precancerous laryngeal lesion called leucoplakia demonstrated 50 percent or greater reduction in the lesion size after six months of taking folate supplements. Encouraging Results for Folic Acid for Cancer Prevention Small study in CANCER indicates finds that 31 of 43 patients with the precancerous laryngeal lesion called leucoplakia demonstrated 50 percent or greater reduction in the lesion size after six months of taking folate supplements. Encouraging Results for Folic Acid for Cancer Prevention Small study in CANCER indicates finds that 31 of 43 patients with the precancerous laryngeal lesion called leucoplakia demonstrated 50 percent or greater reduction in the lesion size after six months of taking folate supplements. Encouraging Results for Folic Acid for Cancer Prevention Small study in CANCER indicates finds that 31 of 43 patients with the precancerous laryngeal lesion called leucoplakia demonstrated 50 percent or greater reduction in the lesion size after six months of taking folate supplements. Encouraging Results for Folic Acid for Cancer Prevention Small study in CANCER indicates finds that 31 of 43 patients with the precancerous laryngeal lesion called leucoplakia demonstrated 50 percent or greater reduction in the lesion size after six months of taking folate supplements. Encouraging Results for Folic Acid for Cancer Prevention Small study in CANCER indicates finds that 31 of 43 patients with the precancerous laryngeal lesion called leucoplakia demonstrated 50 percent or greater reduction in the lesion size after six months of taking folate supplements. Encouraging Results for Folic Acid for Cancer Prevention Small study in CANCER indicates finds that 31 of 43 patients with the precancerous laryngeal lesion called leucoplakia demonstrated 50 percent or greater reduction in the lesion size after six months of taking folate supplements. Encouraging Results for Folic Acid for Cancer Prevention Small study in CANCER indicates finds that 31 of 43 patients with the precancerous laryngeal lesion called leucoplakia demonstrated 50 percent or greater reduction in the lesion size after six months of taking folate supplements. Encouraging Results for Folic Acid for Cancer Prevention Small study in CANCER indicates finds that 31 of 43 patients with the precancerous laryngeal lesion called leucoplakia demonstrated 50 percent or greater reduction in the lesion size after six months of taking folate supplements. Bayer Pharma Signs Agreement with Vitiva Bayer Pharma, Slovenia and Vitiva, Slovenia announced today a new broad technology collaboration, based on exclusive isolation of esters from marigold flower, with Bayer Pharma has registering a patent for a natural OTC product worldwide based on marigold flower extracts. Bayer Pharma Signs Agreement with Vitiva Bayer Pharma, Slovenia and Vitiva, Slovenia announced today a new broad technology collaboration, based on exclusive isolation of esters from marigold flower, with Bayer Pharma has registering a patent for a natural OTC product worldwide based on marigold flower extracts. Bayer Pharma Signs Agreement with Vitiva Bayer Pharma, Slovenia and Vitiva, Slovenia announced today a new broad technology collaboration, based on exclusive isolation of esters from marigold flower, with Bayer Pharma has registering a patent for a natural OTC product worldwide based on marigold flower extracts. Bayer Pharma Signs Agreement with Vitiva Bayer Pharma, Slovenia and Vitiva, Slovenia announced today a new broad technology collaboration, based on exclusive isolation of esters from marigold flower, with Bayer Pharma has registering a patent for a natural OTC product worldwide based on marigold flower extracts. Bayer Pharma Signs Agreement with Vitiva Bayer Pharma, Slovenia and Vitiva, Slovenia announced today a new broad technology collaboration, based on exclusive isolation of esters from marigold flower, with Bayer Pharma has registering a patent for a natural OTC product worldwide based on marigold flower extracts. Bayer Pharma Signs Agreement with Vitiva Bayer Pharma, Slovenia and Vitiva, Slovenia announced today a new broad technology collaboration, based on exclusive isolation of esters from marigold flower, with Bayer Pharma has registering a patent for a natural OTC product worldwide based on marigold flower extracts. ReGen Signs First Commercialisation Deal for Colostrinin(TM) with Metagenics Company has entered into an exclusive licence agreement with Metagenics, Inc. for the commercialisation of ReGen's Colostrinin(TM) as a human nutraceutical in North America. ReGen Signs First Commercialisation Deal for Colostrinin(TM) with Metagenics Company has entered into an exclusive licence agreement with Metagenics, Inc. for the commercialisation of ReGen's Colostrinin(TM) as a human nutraceutical in North America. ReGen Signs First Commercialisation Deal for Colostrinin(TM) with Metagenics Company has entered into an exclusive licence agreement with Metagenics, Inc. for the commercialisation of ReGen's Colostrinin(TM) as a human nutraceutical in North America. ReGen Signs First Commercialisation Deal for Colostrinin(TM) with Metagenics Company has entered into an exclusive licence agreement with Metagenics, Inc. for the commercialisation of ReGen's Colostrinin(TM) as a human nutraceutical in North America. ReGen Signs First Commercialisation Deal for Colostrinin(TM) with Metagenics Company has entered into an exclusive licence agreement with Metagenics, Inc. for the commercialisation of ReGen's Colostrinin(TM) as a human nutraceutical in North America. ReGen Signs First Commercialisation Deal for Colostrinin(TM) with Metagenics Company has entered into an exclusive licence agreement with Metagenics, Inc. for the commercialisation of ReGen's Colostrinin(TM) as a human nutraceutical in North America. Indena and Nerviano Medical Sciences Agree To Scale Up New High Potency Molecules Companies announce a co-development agreement, under which Indena has commissioned Nerviano to handle the scale up and manufacturing of two new drug candidates for preclinical and clinical development: IDN 5404 and IDN 5243. Indena and Nerviano Medical Sciences Agree To Scale Up New High Potency Molecules Companies announce a co-development agreement, under which Indena has commissioned Nerviano to handle the scale up and manufacturing of two new drug candidates for preclinical and clinical development: IDN 5404 and IDN 5243. Indena and Nerviano Medical Sciences Agree To Scale Up New High Potency Molecules Companies announce a co-development agreement, under which Indena has commissioned Nerviano to handle the scale up and manufacturing of two new drug candidates for preclinical and clinical development: IDN 5404 and IDN 5243. Indena and Nerviano Medical Sciences Agree To Scale Up New High Potency Molecules Companies announce a co-development agreement, under which Indena has commissioned Nerviano to handle the scale up and manufacturing of two new drug candidates for preclinical and clinical development: IDN 5404 and IDN 5243. Indena and Nerviano Medical Sciences Agree To Scale Up New High Potency Molecules Companies announce a co-development agreement, under which Indena has commissioned Nerviano to handle the scale up and manufacturing of two new drug candidates for preclinical and clinical development: IDN 5404 and IDN 5243. EAS Workshop: The Practical Implications of the EU's Nutrition and Health Claims Regulation EAS is offering the opportunity to join a 'problem solving' workshop on the EU Regulations on nutrition and health claims and 'fortifed foods', September 13, 2006, at the Radisson Sas Royal Hotel, Brussels EAS Workshop: The Practical Implications of the EU's Nutrition and Health Claims Regulation EAS is offering the opportunity to join a 'problem solving' workshop on the EU Regulations on nutrition and health claims and 'fortifed foods', September 13, 2006, at the Radisson Sas Royal Hotel, Brussels EAS Workshop: The Practical Implications of the EU's Nutrition and Health Claims Regulation EAS is offering the opportunity to join a 'problem solving' workshop on the EU Regulations on nutrition and health claims and 'fortifed foods', September 13, 2006, at the Radisson Sas Royal Hotel, Brussels EAS Workshop: The Practical Implications of the EU's Nutrition and Health Claims Regulation EAS is offering the opportunity to join a 'problem solving' workshop on the EU Regulations on nutrition and health claims and 'fortifed foods', September 13, 2006, at the Radisson Sas Royal Hotel, Brussels EAS Workshop: The Practical Implications of the EU's Nutrition and Health Claims Regulation EAS is offering the opportunity to join a 'problem solving' workshop on the EU Regulations on nutrition and health claims and 'fortifed foods', September 13, 2006, at the Radisson Sas Royal Hotel, Brussels EAS Workshop: The Practical Implications of the EU's Nutrition and Health Claims Regulation EAS is offering the opportunity to join a 'problem solving' workshop on the EU Regulations on nutrition and health claims and 'fortifed foods', September 13, 2006, at the Radisson Sas Royal Hotel, Brussels EAS Workshop: The Practical Implications of the EU's Nutrition and Health Claims Regulation EAS is offering the opportunity to join a 'problem solving' workshop on the EU Regulations on nutrition and health claims and 'fortifed foods', September 13, 2006, at the Radisson Sas Royal Hotel, Brussels EAS Workshop: The Practical Implications of the EU's Nutrition and Health Claims Regulation EAS is offering the opportunity to join a 'problem solving' workshop on the EU Regulations on nutrition and health claims and 'fortifed foods', September 13, 2006, at the Radisson Sas Royal Hotel, Brussels Provexis Announces Exclusivity Agreement Company has entered into an exclusivity agreement for a period of 12 months with a major global branded food business for the joint development and use of its patented Fruitflow(TM) heart-health technology. Provexis Announces Exclusivity Agreement Company has entered into an exclusivity agreement for a period of 12 months with a major global branded food business for the joint development and use of its patented Fruitflow(TM) heart-health technology. Provexis Announces Exclusivity Agreement Company has entered into an exclusivity agreement for a period of 12 months with a major global branded food business for the joint development and use of its patented Fruitflow(TM) heart-health technology. Provexis Announces Exclusivity Agreement Company has entered into an exclusivity agreement for a period of 12 months with a major global branded food business for the joint development and use of its patented Fruitflow(TM) heart-health technology. Provexis Announces Exclusivity Agreement Company has entered into an exclusivity agreement for a period of 12 months with a major global branded food business for the joint development and use of its patented Fruitflow(TM) heart-health technology. Provexis Announces Exclusivity Agreement Company has entered into an exclusivity agreement for a period of 12 months with a major global branded food business for the joint development and use of its patented Fruitflow(TM) heart-health technology. UK: Views Sought on Noni Juice Opinion The expert scientific committee that advises the UK Food Standards Agency on novel foods is calling for comments on its draft opinion of a noni juice product. UK: Views Sought on Noni Juice Opinion The expert scientific committee that advises the UK Food Standards Agency on novel foods is calling for comments on its draft opinion of a noni juice product. UK: Views Sought on Noni Juice Opinion The expert scientific committee that advises the UK Food Standards Agency on novel foods is calling for comments on its draft opinion of a noni juice product. UK: Views Sought on Noni Juice Opinion The expert scientific committee that advises the UK Food Standards Agency on novel foods is calling for comments on its draft opinion of a noni juice product. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Spotlight on Savory Side Dishes Spotlight on Savory Side Dishes Spotlight on Savory Side Dishes Another Reason to Choose Healthy Lifestyle Habits Another Reason to Choose Healthy Lifestyle Habits	~Netherlands's Largest Retailer Launches Margarine Spread, Yogurt and Two Yogurt Drinks Targeted at Lowering Cholesterol~ Vancouver, Canada Forbes Medi-Tech Inc. (TSX:FMI and NASDAQ:FMTI) today announced that the Netherlands's largest retailer, Albert Heijn, has launched a range of cholesterol-lowering dairy products incorporating Forbes Medi-Tech's cholesterol-lowering ingredient, Reducol(tm). The product range, marketed under the Albert Heijn private label brand, will include: a margarine spread, a spoonable yogurt, and 'original' and 'strawberry flavor' yogurt drinks. "The Netherlands offers a unique opportunity for Reducol(tm) where phytosterols, the key ingredients in Reducol(tm), are a standard feature of 'heart-healthy' products," said Charles Butt, President and CEO of Forbes Medi-Tech. "As The Netherlands' largest supermarket chain, Albert Heijn's size and distribution network will be a tremendous asset in launching a range of Reducol(tm)-based dairy products in a market already versed in heart-healthy solutions based on phytosterols. The combination of Albert Heijn's retail strength and Reducol(tm)'s clinically proven ability to help lower cholesterol will be a winning combination." The cholesterol lowering products are scheduled to be available Monday, June 19th. Reducol(tm)-based products, when consumed in recommended amounts and combined with a prudent diet and regular exercise, may help customers lower their cholesterol by up to 24%. "Our research has found that more and more of our customers are looking to eat healthier and are particularly interested in lowering their cholesterol," said Bas Hauwert, Category Manager at Albert Heijn. "Based on the recent successes in other European markets, we felt that launching a line of Reducol(tm)-based dairy products would be appealing to our customers." About Reducol(tm) Reducol(tm) is a unique ingredient containing plant sterols and stanols, commonly known as phytosterols, or "sterols". The combination of a prudent diet and consumption of products containing the recommended amount of Reducol(tm) may help consumers lower their cholesterol by up to 24%. Additional information on Reducol(tm) can be found at www.reducol.com About Albert Heijn With approximately 700 stores, Albert Heijn is the largest supermarket chain in the Netherlands. Albert Heijn stores serve approximately 2.5 million people each week. The company's goal is to make everyday products affordable for customers and to provide them with a unique offering. As the largest supplier of grocery products in the Netherlands, Albert Heijn plays a significant role in the sphere of tasty and healthy food and beverages. By introducing cholesterol-lowering products under its private label, Albert Heijn will make them available to a wide group of consumers. About Forbes Medi-Tech Inc. Forbes Medi-Tech Inc. is a life sciences company dedicated to the research, development and commercialization of innovative products for the prevention and treatment of cardiovascular disease (CVD). Our vision is to develop and market products along a treatment continuum that CVD savvy consumers, healthcare professionals and specialized CVD research and healthcare institutions will identify, recommend and seek. Our business strategy is to develop and commercialize proprietary compounds to address the unmet needs of patients within the cardiovascular disease market. # # # NASDAQ and the Toronto Stock Exchange have not reviewed and do not accept responsibility for the adequacy or accuracy of the content of this News Release. Forbes Medi-Tech ("Forbes" or the "Company") has relied solely on Albert Heijn for the information about Albert Heijn provided in this News Release and the Company disclaims any liability with respect to such information. Forbes disclaims responsibility for information contained in any linked or referenced website, and such links and references do not constitute an endorsement by Forbes of those or any other website. This News Release contains forward-looking statements regarding Reducol(tm), products containing Reducol(tm), and the Company's strategy and vision, which statements can be identified by the use of forward-looking terminology such as "will", "opportunity", "may", "up to", "scheduled", "looking to", "strategy", "vision", "to develop" or comparable terminology referring to future events or results. The Company's actual results could differ materially from those anticipated in these forward-looking statements as a result of numerous factors, including the Company's reliance on Albert Heijn for performance; uncertainty regarding market acceptance and demand for products containing Reducol(tm); uncertainty whether the Albert Heijn products will be available as scheduled; product development risks; intellectual property risks; manufacturing risks and the Company's dependency on Phyto-Source LP, its manufacturer of Reducol(tm); product liability and insurance risks; uncertainty as to future sales volumes and pricing; the effect of competition; the need for new customers; the need for regulatory approvals, which are uncertain; changes in business strategy or development plans; exchange rate fluctuations; and the Company's need for future funding; any of which could cause actual results to vary materially from current results or the Company's anticipated future results. See the Company's reports filed with the Canadian and U.S. securities regulatory authorities from time to time for cautionary statements identifying important factors with respect to such forward-looking statements, including certain risks and uncertainties, that could cause actual results to differ materially from results referred to in forward-looking statements. The Company assumes no obligation to update the information contained in this News Release.
Powered By Traffic Booster Absolute News Manager Plug-in by Xigla Software